{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:03:52Z","timestamp":1789736632267,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Application Medical Research Project of Hefei Municipal Health Commission","award":["Hwk2024qlyb001"],"award-info":[{"award-number":["Hwk2024qlyb001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59162-x","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:16:52Z","timestamp":1782346612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clofibrate downregulates DNA damage response proteins via the MELK-AKT-mTOR axis in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Haohao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"59162_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"59162_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Primers 5, 66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"59162_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218273","author":"AM Wengner","year":"2020","unstructured":"Wengner, A. M., Scholz, A. & Haendler, B. Targeting DNA damage response in prostate and breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21218273 (2020).","journal-title":"Int J Mol Sci."},{"key":"59162_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110708","volume":"131","author":"S Padhi","year":"2020","unstructured":"Padhi, S., Nayak, A. K. & Behera, A. Type II diabetes mellitus: A review on recent drug based therapeutics. Biomed. Pharmacother. 131, 110708. https:\/\/doi.org\/10.1016\/j.biopha.2020.110708 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"59162_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3923\/pjbs.2023.15.22","volume":"26","author":"AS Alhegaili","year":"2023","unstructured":"Alhegaili, A. S. Role of DNA repair deficiency in cancer development. Pak. J. Biol. Sci. 26, 15\u201322. https:\/\/doi.org\/10.3923\/pjbs.2023.15.22 (2023).","journal-title":"Pak. J. Biol. Sci."},{"key":"59162_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s11912-024-01560-3","volume":"26","author":"GR Daly","year":"2024","unstructured":"Daly, G. R. et al. Screening and testing for homologous recombination repair deficiency (HRD) in breast cancer: An overview of the current global landscape. Curr. Oncol. Rep. 26, 890\u2013903. https:\/\/doi.org\/10.1007\/s11912-024-01560-3 (2024).","journal-title":"Curr. Oncol. Rep."},{"key":"59162_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/genes15020162","author":"U Ali","year":"2024","unstructured":"Ali, U., Vungarala, S. & Tiriveedhi, V. Genomic features of homologous recombination deficiency in breast cancer: Impact on testing and immunotherapy. Genes Basel https:\/\/doi.org\/10.3390\/genes15020162 (2024).","journal-title":"Genes Basel"},{"key":"59162_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.102609","volume":"51","author":"Q Xu","year":"2020","unstructured":"Xu, Q. et al. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. EBioMedicine 51, 102609. https:\/\/doi.org\/10.1016\/j.ebiom.2019.102609 (2020).","journal-title":"EBioMedicine"},{"key":"59162_CR9","first-page":"4421","volume":"11","author":"M Oshi","year":"2021","unstructured":"Oshi, M. et al. MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy. Am. J. Cancer Res. 11, 4421\u20134437 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"59162_CR10","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1038\/s41388-019-0917-0","volume":"38","author":"VS Thakur","year":"2019","unstructured":"Thakur, V. S., Aguila, B., Brett-Morris, A., Creighton, C. J. & Welford, S. M. Spermidine\/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness. Oncogene 38, 6794\u20136800. https:\/\/doi.org\/10.1038\/s41388-019-0917-0 (2019).","journal-title":"Oncogene"},{"key":"59162_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/15384101.2023.2174339","volume":"22","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis. Cell Cycle 22, 1077\u20131100. https:\/\/doi.org\/10.1080\/15384101.2023.2174339 (2023).","journal-title":"Cell Cycle"},{"key":"59162_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.116818","volume":"483","author":"YC Chen","year":"2024","unstructured":"Chen, Y. C. et al. Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers. Toxicol. Appl. Pharmacol. 483, 116818. https:\/\/doi.org\/10.1016\/j.taap.2024.116818 (2024).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"59162_CR13","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.18632\/oncotarget.6402","volume":"7","author":"K Chandran","year":"2016","unstructured":"Chandran, K., Goswami, S. & Sharma-Walia, N. Implications of a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) ligand clofibrate in breast cancer. Oncotarget 7, 15577\u201315599. https:\/\/doi.org\/10.18632\/oncotarget.6402 (2016).","journal-title":"Oncotarget"},{"key":"59162_CR14","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: Therapeutic target database describing target druggability information. Nucleic Acids Res. 52, D1465-d1477. https:\/\/doi.org\/10.1093\/nar\/gkad751 (2024).","journal-title":"Nucleic Acids Res."},{"key":"59162_CR15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170 (2010).","journal-title":"Bioinformatics"},{"key":"59162_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"59162_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat. Commun."},{"key":"59162_CR18","doi-asserted-by":"publisher","first-page":"D964","DOI":"10.1093\/nar\/gkac1066","volume":"51","author":"S Guo","year":"2023","unstructured":"Guo, S. et al. GPSAdb: A comprehensive web resource for interactive exploration of genetic perturbation RNA-seq datasets. Nucleic Acids Res. 51, D964-d968. https:\/\/doi.org\/10.1093\/nar\/gkac1066 (2023).","journal-title":"Nucleic Acids Res."},{"key":"59162_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. BEST: A web application for comprehensive biomarker exploration on large-scale data in solid tumors. J. Big Data 10, 165. https:\/\/doi.org\/10.1186\/s40537-023-00844-y (2023).","journal-title":"J. Big Data"},{"key":"59162_CR20","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1038\/s41598-024-59845-3","volume":"14","author":"A Magalh\u00e3es","year":"2024","unstructured":"Magalh\u00e3es, A. et al. A high-cholesterol diet promotes the intravasation of breast tumor cells through an LDL-LDLR axis. Sci. Rep. 14, 9471. https:\/\/doi.org\/10.1038\/s41598-024-59845-3 (2024).","journal-title":"Sci. Rep."},{"key":"59162_CR21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne, N. et al. Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation. Endocr. Rev. 39, 760\u2013802. https:\/\/doi.org\/10.1210\/er.2018-00064 (2018).","journal-title":"Endocr. Rev."},{"key":"59162_CR22","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/1078-0432.Ccr-23-3433","volume":"30","author":"RB Ross","year":"2024","unstructured":"Ross, R. B. et al. PPAR\u03b1 agonism enhances immune response to radiotherapy while dietary oleic acid results in counteraction. Clin. Cancer Res. 30, 1916\u20131933. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-3433 (2024).","journal-title":"Clin. Cancer Res."},{"key":"59162_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12967-024-05323-3","volume":"22","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Genome wide-scale CRISPR-Cas9 knockout screens identify a fitness score for optimized risk stratification in colorectal cancer. J. Transl. Med. 22, 554. https:\/\/doi.org\/10.1186\/s12967-024-05323-3 (2024).","journal-title":"J. Transl. Med."},{"key":"59162_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-06889-6","volume":"625","author":"MG Cho","year":"2024","unstructured":"Cho, M. G. et al. MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis. Nature 625, 585\u2013592. https:\/\/doi.org\/10.1038\/s41586-023-06889-6 (2024).","journal-title":"Nature"},{"key":"59162_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403485","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. USP25 elevates SHLD2-mediated DNA double-strand break repair and regulates chemoresponse in cancer. Adv. Sci. (Weinh) 11, e2403485. https:\/\/doi.org\/10.1002\/advs.202403485 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"59162_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Simon, M., Seluanov, A. & Gorbunova, V. DNA damage and repair in age-related inflammation. Nat. Rev. Immunol. 23, 75\u201389. https:\/\/doi.org\/10.1038\/s41577-022-00751-y (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"59162_CR27","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1038\/s41467-020-19406-4","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen, L., Martens, W. M. J., Van Hoeck, A. & Cuppen, E. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).","journal-title":"Nat. Commun."},{"key":"59162_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-023-07198-2","volume":"205","author":"IH Lee","year":"2024","unstructured":"Lee, I. H. et al. Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer. Breast Cancer Res. Treat. 205, 181\u2013191. https:\/\/doi.org\/10.1007\/s10549-023-07198-2 (2024).","journal-title":"Breast Cancer Res. Treat."},{"key":"59162_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-024-02049-0","volume":"23","author":"B Tang","year":"2024","unstructured":"Tang, B. et al. Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy. Mol. Cancer 23, 137. https:\/\/doi.org\/10.1186\/s12943-024-02049-0 (2024).","journal-title":"Mol. Cancer"},{"key":"59162_CR30","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1158\/2767-9764.Crc-22-0330","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Maternal embryonic leucine zipper kinase is associated with metastasis in triple-negative breast cancer. Cancer Res. Commun. 3, 1078\u20131092. https:\/\/doi.org\/10.1158\/2767-9764.Crc-22-0330 (2023).","journal-title":"Cancer Res. Commun."},{"key":"59162_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-022-03446-z","volume":"20","author":"Z Xie","year":"2022","unstructured":"Xie, Z., Li, W., Ai, J., Xie, J. & Zhang, X. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K\/AKT\/mTOR signaling pathway. J. Transl. Med. 20, 264. https:\/\/doi.org\/10.1186\/s12967-022-03446-z (2022).","journal-title":"J. Transl. Med."},{"key":"59162_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205529","volume":"10","author":"X Peng","year":"2023","unstructured":"Peng, X. et al. Stellettin B Sensitizes Glioblastoma to DNA-damaging treatments by suppressing PI3K-mediated homologous recombination repair. Adv. Sci. (Weinh). 10, e2205529. https:\/\/doi.org\/10.1002\/advs.202205529 (2023).","journal-title":"Adv. Sci. (Weinh)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59162-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59162-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59162-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:02:27Z","timestamp":1789732947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59162-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59162"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59162-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29139"}}